For US investigators, all new concepts should be submitted through your MSL.
If you do not have an MSL, please email email@example.com
Click Here to access the new Genentech IIS Portal
Welcome to the Roche Investigator Initiated Studies Portal
Investigator Initiated Studies (IIS) are clinical studies initiated and managed by a non-pharmaceutical company researcher (e.g. individual investigator, institution, collaborative study group, cooperative group) who takes on the ethical, legal and regulatory responsibilities of the trial sponsor for the conduct and management of the study as defined by all applicable laws and regulations. By submitting your IIS proposal through this site, you are seeking support from Roche for your IIS.
The Roche IIS program is not an unrestricted grant program. There are contractual obligations tied to the receipt of any support for an IIS. IIS concept submissions will be reviewed collectively by a Roche Review Committee. Roche will inform the requester about the outcome and should Roche be interested in the concept submission, the investigator will be contacted by Roche and invited to submit further details and a full protocol on the IIS, which will be further evaluated before a final decision for support is made. Please note that submission of an IIS proposal does not guarantee support from Roche.
Please click here
to download the IIS Sponsor Reference Guide for information on how to register and submit studies.
© 2018 F. Hoffmann-La Roche Ltd Legal Statement
This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin.